CRISPR-Based Anti-Viral Therapy Could One Day Foil the Flu—and COVID-19

Summary Sentence: 
A CRISPR system—targeting viral RNA instead of human DNA—could work as an inhaled anti-viral therapeutic that can be preprogrammed to seek out and foil potentially almost any flu strain and many other respiratory viruses.
Story Link: 
In the News Thumbnail: 
Updated Date: 
03/16/2021 - 10:26